Suppr超能文献

胸外科医生施行的微创肺癌手术与开胸手术同样有效。

Minimally Invasive Lung Cancer Surgery Performed by Thoracic Surgeons as Effective as Thoracotomy.

机构信息

Daniel J. Boffa and Jessica R. Hoag, Yale School of Medicine, New Haven, CT; Andrzej S. Kosinski, Sunghee Kim, and Patricia A. Cowper, Duke Clinical Research Institute; Betty C. Tong, Duke University School of Medicine, Durham, NC; Anthony P. Furnary, Starr-Wood Cardiac Group, Portland, OR; Mark W. Onaitis, University of California, San Diego School of Medicine, San Diego, CA; Jeffrey P. Jacobs, Johns Hopkins All Children's Heart Institute; Saint Petersburg; Joe B. Putnam Jr, Baptist MD Anderson Cancer Center, Jacksonville, FL; Cameron D. Wright, Massachusetts General Hospital, Boston, MA; and Felix G. Fernandez, Emory University, Atlanta, GA.

出版信息

J Clin Oncol. 2018 Aug 10;36(23):2378-2385. doi: 10.1200/JCO.2018.77.8977. Epub 2018 May 23.

Abstract

Purpose The prevalence of minimally invasive lung cancer surgery using video-assisted thoracic surgery (VATS) has increased dramatically over the past decade, yet recent studies have suggested that the lymph node evaluation during VATS lobectomy is inadequate. We hypothesized that the minimally invasive approach to lobectomy for stage I lung cancer resulted in a longitudinal outcome that was not inferior to thoracotomy. Patients and Methods Patients > 65 years of age who had undergone lobectomy for stage I lung cancer between 2002 and 2013 were analyzed within the Society of Thoracic Surgeons General Thoracic Surgery Database, which had been linked to Medicare data, as part of a retrospective-cohort, noninferiority study. Results A total of 10,597 patients with clinical stage I lung cancer who underwent lobectomy were evaluated (4,448 patients underwent thoracotomy, and 6,149 underwent VATS). VATS patients had a more favorable distribution of all health-related variables, including pulmonary function (59% of VATS patients had intact spirometry v 51% of thoracotomy patients; P < .001). Cox proportional hazards models were performed over two eras to account for an evolving practice standard. The mortality risk associated with the VATS approach was not greater than thoracotomy in either the earlier era (2002 to 2008; hazard ratio, 0.97; 95% CI, 0.87 to 1.09; P = .62) or the more recent era (2009 to 2013; hazard ratio, 0.84; 95% CI, 0.75 to 0.93; P < .001). Kaplan-Meier survival estimates of 2,901 propensity-matched VATS-thoracotomy pairs demonstrated that the 4-year survival associated with VATS (68.6%) was modestly superior to thoracotomy (64.8%; P = .003). The analyses detailed above were replicated in a separate cohort of pathologic stage I patients with similar findings. Conclusion The long-term efficacy of lobectomy for stage I lung cancer performed using the VATS approach by board-certified thoracic surgeons does not seem to be inferior to that of thoracotomy.

摘要

目的

在过去的十年中,采用电视辅助胸腔镜手术(VATS)的微创肺癌手术的流行率急剧增加,但最近的研究表明,VATS 肺叶切除术中的淋巴结评估不充分。我们假设,对于 I 期肺癌,微创肺叶切除术的方法会产生不劣于开胸手术的纵向结果。

方法

在一项回顾性队列非劣效性研究中,我们分析了 2002 年至 2013 年间在胸外科医师学会普通胸外科数据库中接受 I 期肺癌肺叶切除术的年龄>65 岁的患者,该数据库已与医疗保险数据相关联。

结果

共评估了 10597 例临床 I 期肺癌行肺叶切除术的患者(4448 例行开胸手术,6149 例行 VATS)。VATS 患者的所有健康相关变量分布更有利,包括肺功能(59%的 VATS 患者肺活量计检查正常,而开胸手术患者为 51%;P<.001)。Cox 比例风险模型在两个时代进行了分析,以说明不断演变的实践标准。在这两个时代,VATS 方法的死亡率风险都不比开胸手术高,在早期时代(2002 年至 2008 年;风险比,0.97;95%CI,0.87 至 1.09;P=.62)或最近的时代(2009 年至 2013 年;风险比,0.84;95%CI,0.75 至 0.93;P<.001)。对 2901 对倾向匹配的 VATS-开胸手术对进行 Kaplan-Meier 生存估计,结果表明 VATS(68.6%)的 4 年生存率略高于开胸手术(64.8%;P=.003)。在具有相似发现的另一组病理 I 期患者的亚组中,复制了上述分析。

结论

由胸外科委员会认证的胸外科医生使用 VATS 方法进行 I 期肺癌肺叶切除术的长期疗效似乎并不劣于开胸手术。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验